Physician profile
William Henry Goffney
NPI 1679776074
$2,085.84
in general payments reported to CMS, 2019-2025
13 companies · $267 in 2025
The $267 reported for 2025 was less than what a typical Surgical Oncology provider received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $534 · 2022: $112 · 2023: $1,053 · 2024: $121 · 2025: $267.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,440.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,440.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $415.77 | 2019-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Medtronic, INC. | $296.25 | 2023-2024 | Ligasure, Venaseal |
| Organogenesis INC. | $292.77 | 2023-2024 | Puraply |
| Viiv Healthcare Company | $240.61 | 2023-2025 | Apretude |
| Hologic INC | $156.24 | 2019 | |
| Abbvie INC. | $149.04 | 2025 | |
| Heron Therapeutics, INC. | $112.12 | 2022 | |
| Smith+Nephew, INC. | $110.34 | 2019 | |
| Stryker Corporation | $97.61 | 2023 | Mako |
| Tetraphase Pharmaceuticals, INC. | $93.76 | 2019 | |
| Kci USA, INC. | $51.33 | 2019 | |
| Mallinckrodt Enterprises LLC | $42.50 | 2019 | |
| Olympus America INC. | $27.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Goffney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.